Movement Alert｜3SBio Rises 5.51% in Regular Trading, Biotech Sector Rally Combined with Oversold Rebound

Market Focus07-20

On July 20, 3SBio rose 5.51% in regular trading, trading at HK$16.96/share, with turnover of approximately HK$162 million.

On the news front, the biotechnology sector saw broad-based strength, with Remegen up 8.13%, SKB Bio up 7.63%, Akeso up 6.51%, Innovent Bio up 5.06%, and BeiGene up 4.2%, reflecting significant sector linkage. Additionally, 3SBio had previously plunged 9.83% on July 17 after Orient Securities disclosed a disposal of 6.131 million shares at approximately HK$17.87 per share, totaling around HK$110 million. Orient Securities' post-disposal holding fell to approximately 177 million shares, representing a 6.97% stake. The sharp prior decline created short-term oversold rebound demand, which combined with the sector-wide rally to drive today's recovery.

3SBio is a biopharmaceutical company primarily engaged in the development, manufacturing, and commercialization of biologics including Tebiao, Yibiao, and Yisaipu, alongside its CDMO business.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1176721361?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 10:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176721361","market":"hk","top_or_hot":-1,"title":"Movement Alert｜3SBio Rises 5.51% in Regular Trading, Biotech Sector Rally Combined with Oversold Rebound","media":"Market Focus","content":"<p><p>On July 20, 3SBio rose 5.51% in regular trading, trading at HK$16.96/share, with turnover of approximately HK$162 million.</p><p>On the news front, the biotechnology sector saw broad-based strength, with Remegen up 8.13%, SKB Bio up 7.63%, Akeso up 6.51%, Innovent Bio up 5.06%, and BeiGene up 4.2%, reflecting significant sector linkage. Additionally, 3SBio had previously plunged 9.83% on July 17 after Orient Securities disclosed a disposal of 6.131 million shares at approximately HK$17.87 per share, totaling around HK$110 million. Orient Securities' post-disposal holding fell to approximately 177 million shares, representing a 6.97% stake. The sharp prior decline created short-term oversold rebound demand, which combined with the sector-wide rally to drive today's recovery.</p><p>3SBio is a biopharmaceutical company primarily engaged in the development, manufacturing, and commercialization of biologics including Tebiao, Yibiao, and Yisaipu, alongside its CDMO business.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜3SBio Rises 5.51% in Regular Trading, Biotech Sector Rally Combined with Oversold Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜3SBio Rises 5.51% in Regular Trading, Biotech Sector Rally Combined with Oversold Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-20 10:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 20, 3SBio rose 5.51% in regular trading, trading at HK$16.96/share, with turnover of approximately HK$162 million.</p><p>On the news front, the biotechnology sector saw broad-based strength, with Remegen up 8.13%, SKB Bio up 7.63%, Akeso up 6.51%, Innovent Bio up 5.06%, and BeiGene up 4.2%, reflecting significant sector linkage. Additionally, 3SBio had previously plunged 9.83% on July 17 after Orient Securities disclosed a disposal of 6.131 million shares at approximately HK$17.87 per share, totaling around HK$110 million. Orient Securities' post-disposal holding fell to approximately 177 million shares, representing a 6.97% stake. The sharp prior decline created short-term oversold rebound demand, which combined with the sector-wide rally to drive today's recovery.</p><p>3SBio is a biopharmaceutical company primarily engaged in the development, manufacturing, and commercialization of biologics including Tebiao, Yibiao, and Yisaipu, alongside its CDMO business.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1176721361","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176721361","pubTimestamp":1784513693,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 20, 3SBio rose 5.51% in regular trading, trading at HK$16.96/share, with turnover of approximately HK$162 million.On the news front, the biotechnology sector saw broad-based strength, with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"走势提醒|3SBio常规交易上涨5.51%，生物技术板块反弹叠加超卖反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"On July 20, 3SBio rose 5.51% in regular trading, trading at HK$16.96/share, with turnover of approximately HK$162 million.On the news front, the biotechnology sector saw broad-based strength, with Remegen up 8.13%, SKB Bio up 7.63%, Akeso up 6.51%, Innovent Bio up 5.06%, and BeiGene up 4.2%, reflecting significant sector linkage. Additionally, 3SBio had previously plunged 9.83% on July 17 after Orient Securities disclosed a disposal of 6.131 million shares at approximately HK$17.87 per share, totaling around HK$110 million. Orient Securities' post-disposal holding fell to approximately 177 million shares, representing a 6.97% stake. The sharp prior decline created short-term oversold rebound demand, which combined with the sector-wide rally to drive today's recovery.3SBio is a biopharmaceutical company primarily engaged in the development, manufacturing, and commercialization of biologics including Tebiao, Yibiao, and Yisaipu, alongside its CDMO business.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1176721361","isCrawlerRequest":true}